296 related articles for article (PubMed ID: 32781640)
1. Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.
Algohary A; Shiradkar R; Pahwa S; Purysko A; Verma S; Moses D; Shnier R; Haynes AM; Delprado W; Thompson J; Tirumani S; Mahran A; Rastinehad AR; Ponsky L; Stricker PD; Madabhushi A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781640
[No Abstract] [Full Text] [Related]
2. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
3. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
4. Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer.
Li L; Shiradkar R; Tirumani SH; Bittencourt LK; Fu P; Mahran A; Buzzy C; Stricker PD; Rastinehad AR; Magi-Galluzzi C; Ponsky L; Klein E; Purysko AS; Madabhushi A
Eur J Radiol Open; 2023; 10():100496. PubMed ID: 37396490
[TBL] [Abstract][Full Text] [Related]
5. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
[TBL] [Abstract][Full Text] [Related]
6. Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings.
Midya A; Hiremath A; Huber J; Sankar Viswanathan V; Omil-Lima D; Mahran A; Bittencourt LK; Harsha Tirumani S; Ponsky L; Shiradkar R; Madabhushi A
Front Oncol; 2023; 13():1166047. PubMed ID: 37731630
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
9. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer.
Qiu Y; Liu YF; Shu X; Qiao XF; Ai GY; He XJ
Acad Radiol; 2023 Sep; 30 Suppl 1():S1-S13. PubMed ID: 37393175
[TBL] [Abstract][Full Text] [Related]
11. Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.
Wang J; Wu CJ; Bao ML; Zhang J; Wang XN; Zhang YD
Eur Radiol; 2017 Oct; 27(10):4082-4090. PubMed ID: 28374077
[TBL] [Abstract][Full Text] [Related]
12. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
13. Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
Algohary A; Viswanath S; Shiradkar R; Ghose S; Pahwa S; Moses D; Jambor I; Shnier R; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Purysko AS; Verma S; Ponsky L; Stricker P; Madabhushi A
J Magn Reson Imaging; 2018 Feb; ():. PubMed ID: 29469937
[TBL] [Abstract][Full Text] [Related]
14. Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI.
Cheng Y; Xu S; Wang H; Wang X; Niu S; Luo Y; Zhao N
Front Oncol; 2022; 12():1047572. PubMed ID: 36578933
[TBL] [Abstract][Full Text] [Related]
15. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
[TBL] [Abstract][Full Text] [Related]
16. Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer.
Li M; Yang L; Yue Y; Xu J; Huang C; Song B
Front Oncol; 2020; 10():631831. PubMed ID: 33680954
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions.
Brancato V; Aiello M; Basso L; Monti S; Palumbo L; Di Costanzo G; Salvatore M; Ragozzino A; Cavaliere C
Sci Rep; 2021 Jan; 11(1):643. PubMed ID: 33436929
[TBL] [Abstract][Full Text] [Related]
18. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Based on DCE-MRI Improved Diagnostic Performance Compared to BI-RADS Analysis in Identifying Sclerosing Adenosis of the Breast.
Ruan M; Ding Z; Shan Y; Pan S; Shao C; Xu W; Zhen T; Pang P; Shen Q
Front Oncol; 2022; 12():888141. PubMed ID: 35646630
[TBL] [Abstract][Full Text] [Related]
20. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
